4,833 Shares in STERIS plc (NYSE:STE) Purchased by Jump Financial LLC

Jump Financial LLC acquired a new stake in STERIS plc (NYSE:STE - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund acquired 4,833 shares of the medical equipment provider's stock, valued at approximately $993,000.

A number of other institutional investors and hedge funds also recently made changes to their positions in STE. Principal Financial Group Inc. boosted its position in STERIS by 9.5% during the third quarter. Principal Financial Group Inc. now owns 1,114,224 shares of the medical equipment provider's stock worth $270,230,000 after purchasing an additional 96,336 shares during the period. SkyView Investment Advisors LLC increased its holdings in STERIS by 1.6% in the 3rd quarter. SkyView Investment Advisors LLC now owns 3,153 shares of the medical equipment provider's stock valued at $765,000 after buying an additional 51 shares during the period. World Investment Advisors LLC acquired a new position in STERIS in the third quarter worth about $5,171,000. Wilmington Savings Fund Society FSB acquired a new position in shares of STERIS in the 3rd quarter worth approximately $9,949,000. Finally, Tidal Investments LLC lifted its holdings in shares of STERIS by 21.0% during the third quarter. Tidal Investments LLC now owns 12,650 shares of the medical equipment provider's stock valued at $3,068,000 after acquiring an additional 2,193 shares during the period. Institutional investors and hedge funds own 94.69% of the company's stock.

STERIS Stock Down 0.6 %

Shares of NYSE:STE traded down $1.35 during mid-day trading on Friday, reaching $225.00. 368,819 shares of the stock were exchanged, compared to its average volume of 525,239. The company has a market cap of $22.11 billion, a P/E ratio of 47.77 and a beta of 0.87. The stock's 50 day simple moving average is $222.89 and its 200-day simple moving average is $218.95. The company has a quick ratio of 1.40, a current ratio of 2.13 and a debt-to-equity ratio of 0.32. STERIS plc has a one year low of $200.45 and a one year high of $248.24.

STERIS (NYSE:STE - Get Free Report) last announced its quarterly earnings data on Wednesday, February 5th. The medical equipment provider reported $2.32 EPS for the quarter, missing analysts' consensus estimates of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. As a group, equities research analysts predict that STERIS plc will post 9.08 EPS for the current year.

STERIS Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, March 21st. Shareholders of record on Thursday, February 20th were given a dividend of $0.57 per share. This represents a $2.28 annualized dividend and a dividend yield of 1.01%. The ex-dividend date was Thursday, February 20th. STERIS's dividend payout ratio (DPR) is 48.41%.

Wall Street Analyst Weigh In

A number of research analysts have recently issued reports on the stock. Needham & Company LLC reiterated a "hold" rating on shares of STERIS in a research note on Monday, April 7th. JMP Securities reaffirmed a "market outperform" rating and issued a $265.00 target price on shares of STERIS in a research note on Thursday, April 10th. Stephens reaffirmed an "overweight" rating and set a $240.00 price objective on shares of STERIS in a research note on Thursday, February 6th. Finally, Piper Sandler upped their target price on shares of STERIS from $260.00 to $265.00 and gave the company an "overweight" rating in a research note on Monday, February 3rd. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, STERIS currently has a consensus rating of "Moderate Buy" and a consensus target price of $258.75.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.